Legend Biotech Corporation provided earnings guidance for the year ended December 31, 2021. For the year, the company expected to record a loss for the year of approximately USD 365.3 million to USD 397.4 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.01 USD | -7.66% | -3.38% | -33.51% |
Jun. 01 | US lawmakers ask FBI for briefing on GenScript Biotech's links to China | RE |
May. 31 | US lawmakers ask FBI for briefing on GenScript Biotech's links to China | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.51% | 7.29B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Biotech Corporation Provides Earnings Guidance for the Year Ended December 31, 2021